Cooperation in Countering Artemisinin Resistance in Africa: Learning from COVID-19

Philip J Rosenthal¹, Anders Björkman², Mehul Dhorda³, Abdoulaye Djimde⁴, Arjen M Dondorp³, Oumar Gaye⁵, Philippe J Guerin^{6

7}, Elizabeth Juma⁸, Dominic P Kwiatkowski⁹, Laura Merson^{6

7}, Francine Ntoumi^{10

11}, Ric N Price^{3

6

7

12}, Jaishree Raman^{13

14}, David S Roos¹⁵, Feiko Ter Kuile^{16

17}, Halidou Tinto¹⁸, Sheena S Tomko¹⁵, Nicholas J White³, Karen I Barnes^{19

20}

Affiliations

¹ University of California, San Francisco, California.
² Malaria Group, University of Karolinska Institutet, Stockholm, Sweden.
³ Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand.
⁴ Malaria Research and Training Centre, University of Science, Techniques and Technologies, Bamako, Mali.
⁵ Department of Medical Parasitology, Faculty of Medicine, Pharmacy and Dentistry, L'Université Cheikh Anta Diop, Dakar, Senegal.
⁶ Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
⁷ WorldWide Antimalarial Resistance Network and Infectious Diseases Data Observatory, Oxford University, Oxford, United Kingdom.
⁸ World Health Organization African Regional Office, Accra, Ghana.
⁹ Wellcome Sanger Institute, Hinxton, United Kingdom.
¹⁰ Fondation Congolaise pour la Recherche Médicale, Brazzaville, Republic of the Congo.
¹¹ Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
¹² Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
¹³ South African National Institute for Communicable Diseases, Johannesburg, South Africa.
¹⁴ Wits Research Institute for Malaria, School of Pathology, University of Witwatersrand, Johannesburg, South Africa.
¹⁵ University of Pennsylvania, Philadelphia, Pennsylvania.
¹⁶ Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
¹⁷ Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya.
¹⁸ Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.
¹⁹ Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
²⁰ WorldWide Antimalarial Resistance Network, Pharmacology Scientific Module, Department of Medicine, University of Cape Town, Cape Town, South Africa.

PMID: 35413688
PMCID: PMC9209939
DOI: 10.4269/ajtmh.22-0148

Editorial

Cooperation in Countering Artemisinin Resistance in Africa: Learning from COVID-19

Philip J Rosenthal et al. Am J Trop Med Hyg. 2022.

. 2022 Apr 12;106(6):1568-1570.

doi: 10.4269/ajtmh.22-0148. Online ahead of print.

Authors

Affiliations

¹ University of California, San Francisco, California.
² Malaria Group, University of Karolinska Institutet, Stockholm, Sweden.
³ Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand.
⁴ Malaria Research and Training Centre, University of Science, Techniques and Technologies, Bamako, Mali.
⁵ Department of Medical Parasitology, Faculty of Medicine, Pharmacy and Dentistry, L'Université Cheikh Anta Diop, Dakar, Senegal.
⁶ Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
⁷ WorldWide Antimalarial Resistance Network and Infectious Diseases Data Observatory, Oxford University, Oxford, United Kingdom.
⁸ World Health Organization African Regional Office, Accra, Ghana.
⁹ Wellcome Sanger Institute, Hinxton, United Kingdom.
¹⁰ Fondation Congolaise pour la Recherche Médicale, Brazzaville, Republic of the Congo.
¹¹ Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
¹² Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
¹³ South African National Institute for Communicable Diseases, Johannesburg, South Africa.
¹⁴ Wits Research Institute for Malaria, School of Pathology, University of Witwatersrand, Johannesburg, South Africa.
¹⁵ University of Pennsylvania, Philadelphia, Pennsylvania.
¹⁶ Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
¹⁷ Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya.
¹⁸ Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.
¹⁹ Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
²⁰ WorldWide Antimalarial Resistance Network, Pharmacology Scientific Module, Department of Medicine, University of Cape Town, Cape Town, South Africa.

PMID: 35413688
PMCID: PMC9209939
DOI: 10.4269/ajtmh.22-0148

No abstract available

PubMed Disclaimer

References

1. Noedl H Se Y Schaecher K Smith BL Socheat D Fukuda MM , 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359: 2619–2620. - PubMed
1. Dondorp AM et al. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455–467. - PMC - PubMed
1. Dhorda M Amaratunga C Dondorp AM , 2021. Artemisinin and multidrug-resistant Plasmodium falciparum: a threat for malaria control and elimination. Curr Opin Infect Dis 34: 432–439. - PMC - PubMed
1. Ariey F et al. 2014. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505: 50–55. - PMC - PubMed
1. World Health Organization , 2021. World Malaria Report 2021. Available at: https://www.who.int/teams/global-malaria-programme/reports/world-malaria.... Accessed January 3, 2021.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Cooperation in Countering Artemisinin Resistance in Africa: Learning from COVID-19

Affiliations

Cooperation in Countering Artemisinin Resistance in Africa: Learning from COVID-19

Authors

Affiliations

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources